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Research
Results from clinical, epidemiologic, and 
  animal studies together suggest that both 
short-term and long-term exposure to ele-
vated levels of traffic have adverse effects on 
pulmonary and cardiovascular systems (Brook 
2005; Brugge et al. 2007). Three interrelated 
biological pathways have been described to 
explain the mechanisms of action between 
inhaled pollutants, the lung, and the heart: 
a) disruption of the autonomic nervous sys-
tem through irritant receptors and pulmonary 
nerve reflexes; b) stimulation of proinflamma-
tory and pro-oxidative processes in the lung; 
and c) translocation of ultrafine particulates 
(UFP) (< 0.1 µm in aerodynamic diameter) 
components of air pollution directly into sys-
temic circulation, eventually reaching the car-
diovascular system (Brook 2008; Donaldson 
et al. 2005; Routledge and Ayres 2005). 
Disruption of the autonomic nervous system, 
inflammation, and oxidative stress are cross-
promoting (Brook 2005), and disentangling 
this network of responses to traffic exposure 
has proved especially challenging in popula-
tions with preexisting conditions that exhibit 
complicated natural histories and treatment 
regimens.
Prior studies of C-reactive protein (CRP) 
have found associations with traffic-related 
exposures, although only one study focused 
on residential traffic exposure (Delfino et al. 
2008). Pulse pressure (PP) has been reported 
in several studies as a strong predictor of 
adverse coronary outcomes and, for older 
populations, a stronger predictor than systolic 
blood pressure (SBP) (Blacher et al. 2000; 
Franklin et al. 2001; Haider et al. 2003; 
Zakopoulos et al. 2001). Several studies have 
examined associations between blood pressure 
and air pollution, although a limited number 
of these have examined PP (Auchincloss et al. 
2008). To our knowledge, no prior study has 
evaluated the association of CRP, blood pres-
sure measures, and residential traffic exposure 
using either direct measurements or other 
traffic indices at the local scale. The purpose 
of this study was to assess the impact of resi-
dential traffic exposure on systemic inflamma-
tion and PP in a cohort of older adults with 
relatively high prevalence of comorbidities 
associated with elevated inflammation. We 
hypothesized that individuals with conditions 
associated with elevated inflammation would 
have an increased inflammatory and blood 
pressure response to traffic stress. Further, we 
hypothesized that by assessing residential traf-
fic exposure using several different traffic indi-
ces for local impacts near busy roads, as well 
as traffic density at the level of traffic analysis 
zones (TAZ), consistent and contrasting pat-
terns of response would be seen, providing 
evidence for or against the alternate pathways 
between exposure and disease.
Methods
Study design and population. This cross-
sectional analysis is part of a longitudinal 
cohort study on stress, nutrition, health, and 
aging conducted by the Boston Puerto Rican 
Center for Population Health and Health 
Disparities (CPHHD) at Tufts University. 
Health disparities previously documented 
in the Puerto Rican older adult population, 
including higher rates of diabetes and hyper-
tension, prompted the larger study (Tucker 
2005). Health status, demographic, blood, 
and genetic data were collected from 2004 
to 2006 for 1,017 older Puerto Rican adults 
(45–75 years of age) recruited primarily 
through door-to-door enumeration (approxi-
mately 84%), with additional participants 
identified randomly during major citywide 
activities. Study design has been described 
elsewhere (Tucker 2005).
Because of the differing hypotheses under 
study, the selection criteria did not include 
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Ba c k g r o u n d: Traffic exposure may increase cardiovascular disease (CVD) risk via systemic 
  inflammation and elevated blood pressure, two important clinical markers for managing disease 
progression.
oBjectives: We assessed degree and consistency of association between traffic exposure indicators 
as predictors of C-reactive protein (CRP) and pulse pressure (PP) in an adult U.S. Puerto Rican 
population (n = 1,017).
Me t h o d s : Cross-sectional information on health and demographics and blood data was col-
lected. Using multiple linear regression, we tested for associations between CRP, PP, and six traffic 
exposure indicators including residential proximity to roads with > 20,000 vehicles/day and traffic 
density [vehicle miles traveled per square mile (VMT/mi2)]. Diabetes and obesity [body mass index 
(BMI) ≥ 30 kg/m2] were tested as effect modifiers.
re s u l t s: CRP was positively associated with traffic density in the total population [36% CRP dif-
ference with 95% confidence interval (CI) 2.5–81%] for residence within the highest versus lowest 
VMT/mi2 level. With BMI ≥ 30, CRP showed significant positive associations with five of six traffic 
indices including residence ≤ 200 m versus > 200 m of a roadway [22.7% CRP difference (95% CI, 
3.15–46.1)] and traffic density in the third highest versus lowest VMT/mi2 level [28.1% difference 
(95% CI, 1.0–62.6)]. PP was positively associated with residence within ≤ 100 m of a roadway for 
the total population [2.2 mmHg (95% CI, 0.13–4.3 mmHg)] and persons with BMI ≥ 30 [3.8 
mmHg (95% CI, 0.88–6.8)]. Effect estimates approximately doubled for residence within ≤ 200 m 
of two or more roadways, particularly in persons with diabetes [8.1 mmHg (95% CI, 2.2–14.1)].
co n c l u s i o n s: Traffic exposure at roadway volumes as low as 20,000–40,000 vehicles/day may 
increase CVD risk through adverse effects on blood pressure and inflammation. Individuals with 
elevated inflammation profiles, that is, BMI ≥ 30, may be more susceptible to the effects of traffic 
exposure.
key w o r d s : C-reactive protein, inflammation, Puerto Rican, pulse pressure, residential traffic expo-
sure, traffic analysis zone, traffic density, traffic proximity. Environ Health Perspect 118:803–811 
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traffic considerations. Participants resided pri-
marily in the greater Boston, Massachusetts, 
area, with approximately 70% in the city of 
Boston. An additional 8–10% of participants 
resided in Chelsea and Lawrence, respectively, 
two areas of relatively high Puerto Rican den-
sity, with the remainder in surrounding cities 
and towns.
Data collection. Interviews were collected 
in the homes of the participants by bilingual 
interviewers in either English or Spanish, as 
preferred by the participant. Blood samples 
were collected in the home by a certified phle-
botomist on the day after the home interview. 
Blood pressure measurements were col-
lected by a trained interviewer at three time 
points during the home visit, in duplicate. 
The second and third sets of readings, four 
readings in total, were averaged. Any read-
ings found to be implausible or highly incon-
sistent were not included in the average. PP 
was calculated as the difference between the 
average SBP and diastolic blood pressure 
(DBP) values [see Supplemental Material 
(doi:10.1289/ehp.0901182) for additional 
details]. Anthropometric measurements were 
taken in duplicate, and the average of the two 
measures was used. Body mass index (BMI) 
was calculated as weight in kilograms divided 
by height in meters squared. 
Traffic exposure assessment. We used 
address geocoordinates to characterize resi-
dential traffic exposure at the time of the inter-
view and acquisition of blood data. Residential 
traffic proximity was characterized for road-
ways with at least 20,000 vehicles/day, and 
multidirectional traffic density was charac-
terized in terms of vehicle miles traveled per 
square mile (VMT/mi2) in each of 227 TAZs 
within the study area (Rioux et al. 2010).
We evaluated four indicators of roadway 
proximity: a) residential proximity ≤ 100 m of 
a roadway; b) residential proximity ≤ 200 m 
of a roadway ; c) number of roadways (0, 1, 
or ≥ 2) within 200 m of a residence; and d) a 
three-tiered exposure gradient (≤ 100 m, > 100 
and ≤ 200 m, and > 200 m). The areas within 
100 m or 200 m of either side of a roadway 
are referred to as 100-m and 200-m buffers.
Four traffic density exposure levels were 
defined, each representing an approximate 
2-fold increase in VMT/mi2 across the study 
area, and study participants were assigned 
the traffic density level of the TAZ in which 
they resided [see Supplemental Material 
(doi:10.1289/ehp.0901182) for additional 
details]. A raster-based spatial density analysis 
was also conducted to examine the degree to 
which small TAZs may be influenced by the 
traffic levels of their contiguous TAZ. Density 
values represent a running weighted average of 
vehicle miles traveled within cells 10 × 10 m 
in diameter calculated over a 1,000-m radius 
from the center of each TAZ. Four raster-
based exposure levels were defined, with 
level 4 representing the highest traffic den-
sity. Each level represents a 2-fold increase 
in raster-based VMT, and study participants 
were assigned the value for their residence 
(see Supplemental Materials for additional 
details).
Traffic data were obtained from the 
Central Transportation and Planning Staff 
of the Boston Region Metropolitan Planning 
Organization (MPO). A geographic infor-
mation system–compatible file with traffic 
count station positions and measurement 
data collected by the Massachusetts Highway 
Department from 1997 to 2006 was used to 
identify approximately 60 roads of interest in 
the study area. Counts reflect traffic volumes 
in both directions.
Data analysis. We evaluated the associa-
tion between residential traffic exposure and 
both log-transformed levels of C-reactive 
protein (lnCRP) and PP by multivariate lin-
ear regression using SPSS software (version 
16.0 for Windows; SPSS Inc., Chicago, IL). 
Results for lnCRP were back-transformed 
(exponentiated) to reflect the percent change, 
also called percent difference, in CRP for each 
unit increase in exposure. We use the term 
“percent difference” to avoid confusion, given 
the cross-sectional nature of this study.
We began a model-building process using 
stepwise regression as a screening process to 
evaluate the full set of explanatory variables 
presented in Table 1. These variables were 
Table 1. Baseline characteristics for the 1,017 Boston Puerto Rican Center for Health and Health 
Disparities Study participants, Greater Boston, Massachusetts, USA.
Characteristic
Total sample 
(n = 1,017)
≤ 200 m 
(n = 432)
> 200 m 
(n = 585) p-Value
Basic descriptive
Age (years) 57.8 ± 7.4 57 57 0.464
Female sex  731 (72) 316 415 0.439
Income/poverty ratio < 100 573 (59) 250 323 0.371
Employment  189 (21) 63 126 0.007
Smoking status  0.06
Smoker 235 (23.3) 196 273  
Ex-smoker  303 (30.1) 118 185
Never smoker  469 (46.6) 115 120
Alcohol consumption  0.946
Not current 626 (62.5) 263 362
Current moderate 311 (31.1) 134 177
Current heavy 64 (6.4) 28 36
Educational level  0.07
< 5th grade 237 (23.3) 103 134  
5th–9th grade 263 (25.9) 123 140
9th–12th 360 (35.5) 154 205
Some college 132 (13) 47 86
Some graduate school  23 (2.3) 5 18
Health status 
BMI (kg/m2) 32 ± 6.8 31.9 32.3 0.467
Waist circumference (cm) 102 ± 15.2 1.02 1.02 0.795
Glucose level (mg/dL) 123 ± 54 120 125 0.142
HDL (mg/dL) 44.9 ± 12.6 44.2 45.6 0.116
LDL (mg/dL) 107 ± 34.9 105 109 0.104
SBP (mmHg) 136 ± 18.7 137 135 0.276
DBP (mmHg) 81.1 ± 10.7 80.1 81.3 0.36
PP (mmHg) 54.9 ± 14.6 56.1 54.2 0.04
Hypertension  709 (70.3) 307 402 0.383
Heart attack (self-reported) 94 (9.3) 43 51 0.494
Heart disease (self-reported) 135 (13.3) 54 81 0.541
Medications 
Statins 381 (37.5) 169 212 0.348
Hypertension  563 (55.6) 247 316 0.319
Insulin 108 (10.6) 47 60 0.749
Oral hypoglycemic agents 232 (22.7) 100 132 0.826
Nonsteroidal anti-inflammatory drugs 353 (37.5) 146 207 0.599
Confirmed conditions 
Type 2 diabetes 417 (41.7) 180 237 0.579
Obesity (BMI ≥ 30) 586 (58.3) 236 350 0.093
Inflammatory biomarkers
CRP (mg/L) 3.7 (0–127) 6.5 5.9 0.246
Log-transformed CRP (mg/L) 1.19 ± 1.18 1.24 1.16 0.282
Serum albumin (g/dL) 4.3 ± 0.32 4.24 4.28 0.07
WBC (103 cells/µL) 6.9 ± 2.4 7.1 6.7 0.014
Values are n (%), mean ± SD, when normally distributed, and median (range) when other distribution. p-Values are 
derived from Pearson chi-square for binary variables and t-test for independent samples for continuous variables.Traffic exposure, pulse pressure, and CRP
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chosen based on review of the literature and 
potential to contribute to preexisting inflam-
matory or hypertensive conditions or less than 
optimal management of such conditions. This 
process resulted in a slightly reduced set of 
variables used to adjust the separate outcome 
models for CRP and PP. Both outcomes were 
evaluated with respect to the full population 
as well as stratifications on the basis of BMI 
(< 30 and ≥ 30) and type 2 diabetes (glucose 
≥ 126 mg/dL or taking diabetes medications) 
(Tucker et al. 2000). Both the CRP and PP 
models were adjusted for age, sex, BMI, waist 
circumference, glucose level, high-density 
lipoprotein (HDL), low-density lipoprotein 
(LDL), smoking status, diabetes, prior heart 
attack, heart disease, statin use, white blood 
cell (WBC) count, income/poverty ratio, and 
education. The CRP model also adjusted for 
the genetic variant rs1250 and albumin; the 
PP model was also adjusted for hypertension 
medication. Crude models were evaluated 
separately for each of the traffic variables and 
the two outcomes.
Each of the six traffic variables (four prox-
imity and two density variables) were analyzed 
in separate models against the two outcomes, 
using the same set of outcome-specific covari-
ates. Indicator dummy variables were used 
to evaluate the distance gradient (reference 
level > 200 m), the number of roadways near 
residence (zero as reference level), and the two 
traffic density approaches (the lowest density 
levels as reference levels).
Results
Study population and demographics. 
The mean age of study participants was 
58 ± 7 years, and 72% were women (Table 2). 
The median length of time at their resi-
dence was 5 years, and 21% were employed. 
More than half were current or ex-smokers. 
Approximately 31% reported to be moderate 
drinkers (1–2 drinks/day) and 6.4% to be 
heavy drinkers (> 2 drinks/day). Only half 
had educational levels above the 9th grade.
The median CRP concentration of 
3.7 mg/L was above the high-risk level for 
cardiovascular disease (Pearson et al. 2003). 
Age-based comparisons with the general popu-
lation indicate that, except for older men, 
75th percentile values for men (5.6 mg/L) and 
women (8.6 mg/L) ages 50–59 years and men 
(3.8 mg/L) and women (8.2 mg/L) ages 60–69 
years in this study were generally higher than 
those reported for the National Health and 
Nutrition Examination Survey (NHANES), 
years 1999–2000 (Ford et al. 2004). Mean 
SBP and DBP were 136 ± 18.7 mmHg 
and 81 ± 10.7 mmHg, respectively, and a 
higher percentage of participants had systolic 
(38% > 140 mmHg) compared with diastolic 
(19% > 90 mmHg) hypertension. Mean PP 
was 54.9 ± 14.6. In a population with a mean 
age of 61 years, levels > 50 mmHg have been 
associated with adverse coronary outcomes 
(Haider et al. 2003).
lnCRP, PP, and health status. CRP was 
significantly higher in participants with BMI 
≥ 30 compared with BMI < 30, in those with 
versus those without type 2 diabetes, and in 
those who reported versus those who did not 
report heart disease (Table 2). These results 
are consistent with other studies (Fortmann 
2004). PP was significantly higher in those 
with versus those without diabetes and in those 
who reported they had had a heart attack.
Traffic exposure. Traffic volumes on most 
roads were between 20,000 and 40,000 vehi-
cles/day, with only four roads between 40,000 
and 100,000 vehicles/day and volumes on two 
roads > 100,000 vehicles/day. Less than 5% 
of participants classified as living near a road 
buffer lived near a road with between 40,000 
and 100,000 vehicles/day, and< 3% lived near 
the highest-volume roads. Some individuals 
lived in locations both in proximity to a road 
and near areas of high traffic density; how-
ever, approximately 62% of individuals living 
in the highest two traffic density levels did not 
live within a 100-m buffer, and 37% did not 
live within a 200-m buffer (Table 3). Traffic 
density across the study ranged from 6,500 
to 1,164,000 VMT/mi2, with a median of 
88,000 VMT/mi2 [see Supplemental Material 
(doi:10.1289/ehp.0901182)].
Exposure distribution among those with 
health conditions was relatively equal with 
respect to traffic exposure except for BMI, 
with a significantly lower number (p = 0.031) 
of participants with BMI ≥ 30 living inside 
versus outside of a 100-m roadway buffer 
[see Supplemental Material (doi:10.1289/
ehp.0901182)].
Health outcomes: CRP. In the adjusted 
models, for the total population, a 36.2% dif-
ference [95% confidence interval (CI) 2.5–81] 
in CRP was associated with traffic density 
comparing the highest level (≥ 266,000 
VMT/mi2) with the reference level (< 69,000 
VMT/mi2) (Table 4). An 18.1% difference 
(95% CI, 1.3–37.6) was observed comparing 
the second-highest raster-based density level 
with the reference level. In stratified models, 
individuals with the highest levels of CRP 
(BMI ≥ 30) showed significant associations 
for five of six exposure characterization indi-
ces, and effect estimates were generally con-
sistent with between 22.7 and 41.8 percent 
differences in CRP. When BMI was ≥ 30, a 
22.7% difference (95% CI, 3.15–46) in CRP 
was associated with residing within ≤ 200 m 
compared with > 200 m of a roadway and a 
28% difference (95% CI, 1.0–62.6) was asso-
ciated with residing in the third highest versus 
lowest level of VMT/mi2.
The highest percent difference in CRP 
[71.3% (95% CI, 18.4–147)] was observed 
for individuals without diabetes resid-
ing within the highest versus lowest level of 
VMT/mi2. Changes in CRP were not sig-
nificant for individuals with diabetes. Other 
variables that consistently remained signifi-
cant for the CRP health outcome for the full 
population and stratified models include 
sex, BMI, waist circumference, glucose level, 
HDL, LDL, statin use, albumin, WBC count, 
Table 2. Ln-transformed C-reactive protein concentrations and pulse pressure levels by health status. 
Outcome BMI < 30 BMI ≥ 30 p-Value
No type 2 
diabetes
Type 2 
diabetes p-Value
No prior 
heart attack
Prior heart 
attack p-Value
No heart 
disease
Heart 
disease p-Value
lnCRP (mg/L)  n = 404 n = 565 n = 578 n = 403 n = 890 n = 90 n = 850 n = 130
0.68 ± 1.14 1.54 ± 1.05 0.001 1.07 ± 1.18 1.36 ± 1.15 < 0.001 1.19 ± 1.18 1.12 ± 1.11 0.545 1.13 ± 1.17 1.53 ± 1.11 < 0.001
Pulse pressure n = 415 n = 562 n = 572 n = 400 n = 896 n = 92 n = 858 n = 130
(mmHg) 54.7 ± 14.4 55.1 ± 14.8  0.627  52.5 ± 13.8 58.7 ± 15.2 < 0.001 54.2 ± 14.3 62.3 ± 16.3 < 0.001 54.9 ± 14.7 56 ± 14.5 0.395
Values are mean ± SD. Case numbers vary by outcome based on exclusion criteria of WBC counts for lnCRP. p-Values are based on independent samples t-test.
Table 3. Number (%) of participants residing within traffic proximity categories (≤ 100 m and ≤ 200 m of 
roadways) and traffic density levels (VMT/mi2), Greater Boston, Massachusetts, USA.
 
Proximity 
measure
Traffic density levels (VMT/mi2)
Level 1 
< 69,000
Level 2 
69,000 to < 123,000
Level 3  
123,000 to < 266,000
Level 4 
≥ 266,000 Total
≤ 100 m
No 334 (88) 302 (81) 123 (62) 39 (57) 798
Yes   47 (12)   69 (19)   74 (38) 28 (41) 218
Total 381 371 197 68 1,017
≤ 200 m
No 275 (72) 213 (57)   79 (40) 18 (26) 585
Yes 106 (28) 158 (43) 118 (60) 50 (74) 432
Total 381 371 197 68 1,017Rioux et al.
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and the CRP genetic variant. Crude models 
[see Supplemental Material (doi:10.1289/
ehp.0901182)] were generally consistent with 
the adjusted models, with p-values in some 
cases being slightly lower in the crude models. 
A notable exception includes multiple roadway 
exposure for persons with BMI ≥ 30, where 
CRP was significant in the crude model (56% 
difference; 95% CI, 3.9–135) but not in the 
adjusted model.
Figure 1 presents the percent difference in 
CRP for all cases, individuals with BMI ≥ 30 
and < 30, with and without type 2 diabe-
tes for four exposure variables (≤ 100, ≤ 200, 
multiple roadways, and VMT/mi2).
Pulse pressure. PP was positively associated 
with residence ≤ 100 m of a roadway with a 
difference of 2.2 mmHg (95% CI, 0.13–4.3 
mmHg) for the total population and 3.8 mmHg 
(95% CI, 0.88–6.8) for those with BMI ≥ 30. 
Effect estimates were roughly double for resid-
ing ≤ 200 of two or more roadways, with a dif-
ference of 4.6 mmHg (95% CI, 0.81–8.4) for 
the total population and 6.5 mmHg (95% CI, 
0.89–12.2) for persons with BMI ≥ 30. The 
highest effect estimates for PP [8.1 mmHg 
(95% CI, 2.2–14.1)] were observed for persons 
with diabetes residing within two or more road-
ways (Table 5). Other variables that consistently 
remained significant for the PP outcome for the 
full population and stratified models include 
age, BMI, waist circumference, glucose level, 
LDL, prior heart attack, heart disease, hyperten-
sion medications, and WBC count.
Figure 1 presents differences in PP for all 
cases, individuals with BMI ≥ 30 and < 30, 
diabetes and without diabetes for four exposure 
variables (≤ 100, ≤ 200, multiple roadways, 
and VMT/mi2).
Discussion
CRP and PP are well-established risk factors 
for cardiovascular disease and are elevated 
among individuals with the conditions found 
to be prevalent in the Puerto Rican popula-
tion. Health disparities have been previously 
documented in the Massachusetts Puerto 
Rican older adult population (Tucker 2005; 
Tucker et al. 2000) and include increased 
prevalence of diabetes even among nonobese 
individuals (Bermudez and Tucker 2001), 
poor therapeutic control of glycosolated 
hemoglobin, and higher prevalence of systolic 
hypertension compared with non-Hispanic 
whites (Lin et al. 2002). The inflammatory 
and hypertensive profile seen in this study 
population, although complicated by the use 
of medications such as statins, insulin, oral 
hypoglycemic medications, and antihyperten-
sive medications, may provide insights into 
inherent and acquired susceptibilities as well 
as mediating factors. The health disparities 
reported in this population may indicate a 
higher level of vulnerability to traffic-related 
health effects. Our findings are most gener-
alizable to other age-matched, residence- and 
income-matched populations with similar 
health profiles, namely, elevated BMI.
Differential personal exposure to particles, 
gaseous pollutants, and traffic pollution have 
been associated with lower socioeconomic 
position with respect to education, minority 
status, and income and major roadways have 
been routed through lower-income areas with 
less political and economic power (O’Neill 
et al. 2003). Here we controlled for income/
poverty ratio and educational level in all mod-
els. We also examined as covariates work-
ing status and length of time at residence, 
although neither was observed to be signifi-
cant, or even close to significant, in the mod-
el-building stage. Only 18.5% of this study 
population reported to be working. This is the 
first study of which we are aware that exam-
ines traffic-related health effects in the older 
Puerto Rican population.
Overview of health outcomes. Individuals 
with higher CRP, that is, individuals with 
BMI ≥ 30, had significant associations with 
traffic exposure consistent with inflamma-
tion mediating the effects of traffic exposure. 
Inflammatory processes in the airways and 
lungs can prompt signaling in autonomic 
fibers (Utell et al. 2002), suggesting the two 
pathways interact. Inflammation (Hansson 
2005; Libby and Ridker 2004) and PP (Dart 
and Kingwell 2001) play central roles in the 
development and progression of atherosclero-
sis. There is evidence that PP, acting through 
the promotion of endothelial damage and 
mechanical fatigue, may be both a cause and 
consequence of atherosclerosis, which in turn 
promotes aortic stiffness and increased central 
wave reflection associated with elevated PP 
(Dart and Kingwell 2001).
We also examined SBP and DBP, WBC 
counts, and percent neutrophils, which are the 
most numerous WBCs, as outcomes (detail 
not shown). In persons with BMI ≥ 30 only, 
SBP was positively associated (p = 0.013) with 
proximity ≤ 100 m [4.5 mmHg (95% CI, 
0.46–8.6)], confirmed by the distance gradi-
ent (p = 0.017) variable ≤ 100 m [4.8 (95% 
CI, 0.87–8.76)]. SBP was also positively 
associated (p = 0.045) with traffic density in 
the third versus reference level for persons 
with diabetes [5.6 (95% CI, 0.12–11)]. 
Associations remained significant (p < 0.05) 
after removing the two highest outliers for 
SBP (> 200 mmHg).
For persons with BMI ≥ 30, DBP was 
negatively associated (p = 0.013) with resi-
dence near multiple roadways [–5.4 (95% 
CI, –9.6 to –1.1)] and remained significant 
after removing the two lowest outliers for 
DBP (< 53 mmHg). These findings may par-
tially explain the significant increases in PP 
observed mostly for proximity ≤ 100 m and 
multiple roadways, although the associations 
Table 4. Percent difference (95% CI) in C-reactive protein associated with traffic indices for the complete study group and subgroups.a
All cases Obesity  Diabetes
Traffic index   p-Value Yes p-Value No p-Value Yes p-Value No p-Value
≤ 100 m –2.7 (–18.0 to 15.4) 0.747 –4.3 (–23.2 to 19.2) 0.697 1.3 (–23.4 to 33.9) 0.927 –10.6 (–30.9 to 15.7) 0.393 4.6 (–16.2 to 33.1) 0.645
≤ 200 m 8.9 (–5.3 to 25.4) 0.229 22.7 (3.15 to 46.1) 0.021 –5.1 (–24.9 to 20.2) 0.668 1.5 (–17.6 to 25.2) 0.885 16.1 (–4.3 to 40.6) 0.129
3-Tiered gradient
≤ 100 m  1.4 (–15.0 to 20.9) 0.878 4.6 (–16.5 to 30.9) 0.697 –1.3 (–26.1 to 32) 0.932 –7.9 (–29.5 to 20.2) 0.540 10.9 (–12.6 to 41.1) 0.393
> 100 to ≤ 200 m 17.1 (–1.8 to 39.6) 0.079 41.8 (14.2 to 75.9) 0.002 –8.9 (–32.6 to 22.9) 0.538 11.5 (–14.2 to 44.8) 0.414 21.7 (–4.8 to 55.6) 0.117
No. of roadways
1 roadway 10.3 (–4.7 to 27.6) 0.188 23.9 (3.5 to 48.6) 0.02 –3.7 (–24.7 to 23.1) 0.761 2.5 (–17.7 to 27.9) 0.822 17.8 (–3.6 to 43.9) 0.109
≥ 2 roadways 0.5 (–26.3 to 37.2) 0.973 13.7 (–24.4 to 71.3) 0.535 –12.9 (–46.6 to 42) 0.580 –4.1 (–38.4 to 49.3) 0.853 4.2 (–32.8 to 61.8) 0.853
VMT/mi2 
Level 2 8.0 (–8.1 to 26.9) 0.349 9.6 (–9.9 to 33.5) 0.359 7.8 (–18.7 to 43) 0.600 –5.7 (–25.9 to 20.2) 0.634 16.5 (–6.6 to 45.2) 0.175
Level 3 9.5 (–9.9 to 33.1) 0.360 28.1 (1.0 to 62.6) 0.041 –14.5 (–39.3 to 20.4) 0.369 –2.4 (–27.9 to 32.2) 0.876 18.3 (–8.8 to 53.4) 0.204
Level 4 36.2 (2.5 to 81.1) 0.033 42.5 (–3.1 to 109) 0.072 24.5 (–19.7 to 92.9) 0.326 –7.4 (–41.6 to 46.8) 0.742 71.3 (18.4 to 147) 0.004
Raster density 
Level 2 18.1 (1.3 to 37.6) 0.034 25.9 (4.3 to 51.8) 0.016 8.2 (–16.9 to 40.8) 0.557 17.7 (–6.7 to 48.6) 0.169 20.6 (–2.1 to 48.6) 0.078
Level 3 13.2 (–9.1 to 40.9) 0.267 8.0 (–18.8 to 43.8) 0.595 18.6 (–16.9 to 69.6) 0.344 1.2 (–27.5 to 41.3) 0.942 23.1 (–8.5 to 65.5) 0.169
Level 4 6.6 (–29.3 to 60.6) 0.761 23.0 (–23.5 to 97.6) 0.392 –32.8 (–69.4 to 47.8) 0.322 42.9 (–22.12 to 162) 0.249 –10.7 (–49.4 to 57.8) 0.696
Reference levels were > 100 m for ≤ 100 m; > 200 m for ≤ 200 m and the 3-tiered gradient; 0 (roadways) for number of roadways ≤ 200 m of a residence; and level 1 for VMT/mi2 and raster density.
aAll CRP models were adjusted for age, sex, BMI, waist circumference, glucose level, HDL, LDL, smoking status, diabetes, prior heart attack, heart disease, statin use, albumin, WBC 
count, CRP genetic variant rs1250, income/poverty ratio, and education. Traffic exposure, pulse pressure, and CRP
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in PP are somewhat more consistent for the 
full population, persons with BMI ≥ 30, and 
persons with diabetes. In the full population 
in adjusted models, associations remained 
significant (p < 0.05) for PP and proxim-
ity ≤ 100 m and multiple roadways after 
removing the two lowest outliers for DBP 
(< 53 mmHg). Associations also remained sig-
nificant (p < 0.05) for PP and multiple road-
ways in the full population after removing the 
two highest outliers for SBP (> 200 mmHg) 
but became borderline significant (p = 0.059) 
for proximity ≤ 100 m. Associations for PP 
did not change after removing DBP and SBP 
outliers for persons with BMI ≥ 30.
In persons with BMI ≥ 30 only WBC 
counts were positively associated [0.59 
× 103/mm3 (95% CI, 0.015–1.173)] with 
Figure 1. Percent difference in C-reactive protein (A) and difference in pulse pressure (B) and 95% CIs associated with traffic indices for complete study group 
and subgroups. Abbreviations: ≤ 100 m, location of residence ≤ 100 m of a roadway with more than 20,000 vehicles/day; ≤ 200 m, location of residence ≤ 200 m of 
these roadways; ≥ 2 buffers, location of residence within ≥ 2 200-m buffers of these roadways; VMT-2, VMT-3, VMT-4, traffic density levels associated with 69,000 
to < 123,000 VMT/mi2, 123,000 to < 266,000 VMT/mi2, and ≥ 266,000 VMT/mi2, respectively.
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All cases BMI ≥ 30 BMI < 30 Diabetes No diabetes
All cases BMI ≥ 30 BMI < 30 Diabetes No diabetes
≤ 100 m
≤ 200 m
VMT-2
VMT-3
VMT-4
≥ 2 roadways
≤ 100 m
≤ 200 m
VMT-2
VMT-3
VMT-4
≥ 2 roadways
≤ 100 m
≤ 200 m
VMT-2
VMT-3
VMT-4
≥ 2 roadways
≤ 100 m
≤ 200 m
VMT-2
VMT-3
VMT-4
≥ 2 roadways
≤ 100 m
≤ 200 m
VMT-2
VMT-3
VMT-4
≥ 2 roadways
≤ 100 m
≤ 200 m
VMT-2
VMT-3
VMT-4
≥ 2 roadways
≤ 100 m
≤ 200 m
VMT-2
VMT-3
VMT-4
≥ 2 roadways
≤ 100 m
≤ 200 m
VMT-2
VMT-3
VMT-4
≥ 2 roadways
≤ 100 m
≤ 200 m
VMT-2
VMT-3
VMT-4
≥ 2 roadways
≤ 100 m
≤ 200 m
VMT-2
VMT-3
VMT-4
≥ 2 roadways
Table 5. Difference in pulse pressure (95% CI) associated with all traffic indices for the complete study group and subgroups.a 
All cases Obesity Diabetes
Traffic index   p-Value Yes p-Value No  p-Value Yes p-Value No p-Value
≤ 100 m 2.2 (0.13 to 4.3) 0.038 3.8 (0.88 to 6.8) 0.011 1.2 (–1.8 to 4.1) 0.432 3.2 (–0.24 to 6.8) 0.068 1.5 (–1.1 to 4.1) 0.152
≤ 200 m 0.6 (–1.2 to 2.3) 0.524 1.6 (–0.8 to 3.9) 0.198 –0.19 (–2.7 to 2.3) 0.881 1.2 (–0.89 to 4.9) 0.176 0.46 (–2.6 to 1.7) 0.681
3-Tiered gradient
≤ 100 m  2.0 (0.04 to 3.9) 0.073 3.7 (0.68 to 6.8) 0.017 0.8 (–2.3 to 3.9) 0.605 3.4 (–0.23 to 7.0) 0.066 1.0 (–1.7 to 3.7) 0.468
> 100 to ≤ 200 m –0.9 (–3.1 to 0.9) 0.422 –0.4 (–3.3 to 2.5) 0.789 –1.4 (–4.7 to 1.8) 0.402 –0.56 (–3.1 to 5.2) 0.762 –2.1 (–4.8 to 0.74) 0.149
No. of roadways
1 roadway –0.045 (–1.8 to 1.8) 0.961 0.9 (–1.5 to 3.4) 0.465 –0.88 (–3.5 to 1.7) 0.507 0.9 (–2.1 to 3.9) 0.504 –0.71 (–3.0 to 1.5) 0.516
≥ 2 roadways 4.6 (0.81 to 8.4) 0.018 6.5 (0.89 to 12.2) 0.024 3.8 (–1.2 to 8.9) 0.134 8.1 (2.2 to 14.1) 0.007 1.7 (–3.3 to 6.7) 0.497
VMT/mi2 
Level 2 1.0 (–0.94 to 3.0) 0.302 0.80 (–1.9 to 3.5) 0.559 1.3 (–1.5 to 4.1) 0.404 2.2 (–1.1 to 5.5) 0.188 0.8 (–1.8 to 3.3) 0.553
Level 3 0.98 (–1.4 to 3.4) 0.424 0.78 (–2.5 to 4.0) 0.644 1.9 (–1.8 to 5.4) 0.312 4.1 (–0.01 to 8.3) 0.051 –1.3 (–4.3 to 1.7) 0.383
Level 4 0.87 (–2.6 to 4.3) 0.621 –0.4 (–5.6 to 4.8) 0.876 2.3 (–2.3 to 6.9) 0.328 1.4 (–4.9 to 7.7) 0.661 0.56 (–3.6 to 4.7) 0.778
Raster density 
Level 2 –0.16 (–2.1 to 1.7) 0.871 –0.39 (–2.2 to 2.9) 0.764 –0.49 (–3.3 to 2.3) 0.730 –0.26 (–2.9 to 3.4) 0.875 –0.41 (–2.8 to 1.9) 0.739
Level 3 –0.28 (–2.4 to 2.9) 0.836 –1.0 (–2.8 to 4.8) 0.600 –0.69 (–4.4 to 2.0) 0.713 –0.06 (–4.5 to 4.4) 0.980 –0.74 (–2.6 to 4.1) 0.665
Level 4 –1.1 (–6.4 to 4.2) 0.682 –2.0 (–8.8 to 4.7) 0.556 0.9 (–7.6 to 9.5) 0.824 0.97 (–9.7 to 7.8) 0.827 –0.23 (–6.9 to 6.4) 0.947
Reference levels were > 100 m for ≤ 100 m; > 200 m for ≤ 200 m and the 3-tiered gradient; 0 (roadways) for number of roadways ≤ 200 m of a residence; and level 1 for VMT/mi2 and raster density.
aAll pulse pressure models were adjusted for age, sex, BMI, waist circumference, glucose level, HDL, LDL, smoking status, diabetes, prior heart attack, heart disease, statin use, hyper-
tension medication, WBC count, income/poverty ratio, and education. Rioux et al.
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the distance gradient ≤ 100 m compared with 
> 100 to ≤ 200 m and > 200 m. The asso-
ciation was not confirmed in the proximity 
≤ 100 variable. No significant associations 
were observed for neutrophils.
Overview of traffic indices. Increased traf-
fic density and/or proximity to major road-
ways have been associated with several adverse 
health outcomes related to the heart and lung 
(Gauderman et al. 2005; Hoffmann et al. 
2007, 2009; Kim et al. 2008; Lipfert et al. 
2006; McConnell et al. 2006; Medina-Ramón 
et al. 2008; Tonne et al. 2007). Traffic density 
has been identified as a significant predictor 
of nitrogen oxides (NOx), nitrogen dioxide 
(NO2), particulates < 2.5 µm in aerodynamic 
diameter (PM2.5), the soot content of PM2.5, 
and volatile organic chemicals in a review of 
25 studies using land use regression analysis to 
characterize traffic exposure (Hoek et al. 2008). 
Pollution gradients reported in the vicinity 
of highways in the United States with over 
100,000 vehicles/day show that concentrations 
of ultrafine particles, carbon monoxide (CO), 
black carbon, and NOx drop off exponentially 
with distance (Zhang et al. 2004; Zhu et al. 
2002a, 2002b). Steep declines in UFP concen-
trations have also been reported for a lower-
volume road (30,000 vehicles/day) in England 
(Shi et al. 1999).
We used four methods to assess traffic 
proximity, and two methods were used for 
traffic density. In addition to the 100-m and 
200-m roadway buffers, a distance gradi-
ent was developed to test for the presence 
of a dose–response relationship. Assessment 
of multiple roadway exposure could indicate 
whether impacts were additive or multiplica-
tive. The traffic density variable VMT/mi2 
assessed multidirectional effects common in 
dense urban areas and tested the utility of 
TAZ data for this purpose. The raster-based 
spatial density assessment examined the degree 
to which small-area TAZs may be influenced 
by the traffic levels of contiguous TAZs.
For roadway proximity indices in adjusted 
models, PP was significant for the total popu-
lation, individuals with BMI ≥ 30, and with 
diabetes, whereas CRP was significant for 
individuals with BMI ≥ 30. In crude models, 
CRP was also significant for the full popu-
lation and for individuals without diabetes. 
Roadway proximity ≤ 100 m was significant 
for PP, whereas proximity ≤ 200 m was sig-
nificant for CRP. A disproportionately lower 
number of individuals with BMI ≥ 30 lived 
within versus outside of a 100-m roadway buf-
fer, possibly explaining the lack of association 
for CRP at this distance. PP may be a stron-
ger predictor of traffic proximity among this 
group. An alternate explanation would be the 
different composition of traffic-related air pol-
lution (TRAP) within the two gradients. For 
example, primary emissions comprising largely 
fresh UFP closest to highways differ in chemi-
cal composition from mature UFP formed 
downgradient from the vehicular emission 
source (Brugge et al. 2007). Higher noise lev-
els closer to roadways may be a greater factor 
for PP versus CRP, although evidence associ-
ating noise with individual measures of SBP 
and DBP is inconsistent (Babisch 2006).
Residing near multiple roadways was 
consistently associated with PP, with effect 
estimates approximately double those for the 
proximity variable suggesting additive effects. 
Of the 218 cases residing ≤ 100 m of a road-
way, 74% (n = 162) lived near one roadway 
and 26% (n = 56) resided near two or more 
roadways.
The distance gradient compared residence 
within a certain roadway distance (≤ 100 m 
or > 100 to ≤ 200 m) with the reference of 
> 200 m. These indices were always consistent 
with the proximity indices indicating that ≤ 100 
m was the higher impact zone for PP, but for 
CRP the > 100 to ≤ 200-m zone was more 
relevant, specifically for individuals with BMI 
≥ 30. Aside from the different pollutant and 
noise gradients, building type and design closer 
to roadways and level of activity and time spent 
at home could also be factors contributing to a 
difference in exposure and response.
The two density methods, TAZ-based and 
raster-based, were consistent with each other 
although the smoothing function in the raster-
based density tended to eliminate some of the 
exposure contrast, with more cases shifted into 
lower raster-based density levels compared with 
the higher TAZ-based levels. For three popula-
tion classes [all cases, BMI ≥ 30 and without 
diabetes (crude model)] where raster-based 
density had a significant association with CRP, 
the associations were seen in the second density 
level (level 2) compared with the reference level 
(level 1), whereas with TAZ-based density, 
significant associations were seen in the high-
est density level. The difference in outcomes 
associated with proximity and density may be 
partially explained by a) the distribution of 
individuals who lived in high-traffic density 
areas but did not live within a 100-m or 200-m 
buffer; and b) the general underrepresentation 
of cases in the high-traffic areas—for example, 
60 of 923 cases resided in the highest traffic 
density level.
The lower level of traffic in terms of road-
way volumes or traffic density associated with 
adverse health effects has not been established. 
Studies have used different definitions of what 
constitutes a major roadway. Several studies 
have reported adverse health effects associ-
ated with residing or attending school near 
interstates, highways, and major arterials 
(McConnell et al. 2006; Van Hee et al. 2009) 
or for major roads with vehicle counts that 
ranged from 10,000 to 100,000 (Hoffmann 
et al. 2006, 2007, 2009). Major arterials can 
range from 15,000 to 30,000 vehicles/day. 
These studies did not report the number or 
percentage of subjects living near the lower 
versus higher range of traffic volumes. A lower 
volume threshold common to many of the 
surface roads throughout the study area was 
evaluated in this study, and results strongly 
suggest residence near roadways with traf-
fic volumes between 20,000 and 40,000 
  vehicles/day may be associated with adverse 
outcomes. More than 90% of study partici-
pants resided near roads between 20,000 and 
40,000   vehicles/day. Separate analyses were 
conducted excluding those participants resid-
ing near the highest-volume roads, and results 
were unchanged (not shown).
Consistency with studies of CRP. Some 
prior studies of CRP found associations with 
traffic-related exposures consistent with the 
findings reported here, although only one 
study focused on residential traffic exposure. 
In a study of 29 nonsmoking elderly people 
with a history of coronary artery disease, sig-
nificant associations were reported between 
several markers of inflammation including 
CRP and indoor and outdoor concentrations 
of several traffic-related pollutants including 
PM2.5, elemental carbon, black carbon, par-
ticle number, CO, and NOx (Delfino et al. 
2008). An association with CRP above the 
90th percentile was reported with ultrafine 
traffic-related particles measured at central 
monitors approximately 1 km away from a 
clinic where blood samples were collected 
(Yue et al. 2007). Rückerl et al. (2006) evalu-
ated several pollutant classes related to traffic, 
including concentrations of elemental and 
organic carbon, ultrafine particles from 0.01 
to 0.1 µm, and accumulation mode particle 
counts for particles from 0.1 to 1.0 µm col-
lected from a central monitor. Significant 
associations with CRP above the 90th per-
centile in individuals attending a clinic were 
reported for ultrafine and accumulation mode 
particle fractions. Another study by the same 
authors found no consistent associations with 
CRP and several traffic-related pollutants 
(Rückerl et al. 2007).
Measuring PM2.5 in highway patrol cars, 
Riediker et al. (2004) reported significant asso-
ciations with several inflammatory biomarkers 
including CRP. Using a combination of central 
monitoring and personal micro  environment 
monitoring data for PM2.5, a significant 
associa  tion was reported between CRP and 
ambient levels, particularly among persons with 
diabetes, obesity, and hypertension, including 
combinations of these conditions (Dubowsky 
et al. 2006). One study used central moni-
tors combined with air dispersion modeling to 
predict levels of PM10 (particulates < 10 µm in 
aerodynamic diameter), NO2, sulfur dioxide 
(SO2), and ozone at the postal code level clos-
est to residence but found no association with Traffic exposure, pulse pressure, and CRP
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CRP (Forbes et al. 2009). Our results are gen-
erally consistent with studies reporting associa-
tions with CRP above the 90th percentile. For 
those with preexisting proinflammatory condi-
tions as in this study, individuals with BMI 
≥ 30 had the highest CRP levels compared 
with the other subgroups.
Consistency with studies of PP. Several 
studies have examined associations between 
blood pressure measures and air pollution, 
some of which examined air pollution spe-
cifically related to TRAP. Only one study 
addressed PP and found significant associa-
tions with PP and SBP and PM2.5 based on 
central air monitoring data (Auchincloss et al. 
2008). Distance to roadway and traffic density 
measured as roadway length around a resi-
dence increased these associations but were not 
independently associated with PP and SBP. A 
three-city study examined acute exposure to 
UFP, accumulation mode particles, and PM2.5 
at central air pollution monitors located in 
each city. Small but significant decreases with 
SBP and DBP were reported for all lag times 
from 0 to 5 days (Ibald-Mulli et al. 2004). In 
a controlled experiment of 23 healthy young 
adults (average age 23 ± 10 years), the magni-
tude of change in DBP was associated with the 
organic carbon content of PM2.5, suggesting a 
traffic-related mechanism (Urch et al. 2005). 
Significant changes in SBP were not observed. 
In a study not specifically targeted to traffic 
exposure, small but statistically significant dif-
ferences in SBP (1.79 mmHg per 90 µg/m3 
total suspended particulates and 0.74 mmHg 
per 80 µg/m3 SO2) were reported for 2,607 
men and women 25–64 years of age (Ibald-
Mulli et al. 2004). Cardiac rehabilitation 
patients showed positive associations with SBP, 
DBP, and mean arterial pressure and PM2.5 
measured from central monitors (Zanobetti 
et al. 2004). A recent study designed to test 
the association between air pollution and 
blood pressure, systemic inflammation, and 
endothelial dysfunction reported significant 
increases in DBP and decreases in heart rate 
variability immediately following a controlled 
2-hr exposure to concentrated PM2.5 in an 
area reported to be heavily influenced by traf-
fic (downtown Toronto, ON, Canada) (Brook 
et al. 2009). Because of differences in response 
time, the authors conclude that the imme-
diate-onset increases in blood pressure were 
a result of acute autonomic nervous system 
imbalance and not attributable to increases in 
inflammatory markers or observed increases 
in flow-mediated dilation that decreased sig-
nificantly after 24 hr. Later-onset changes in 
blood pressure may be attributable to these 
mechanisms (Brook et al. 2009).
Two components of traffic exposure are 
relevant to blood pressure measures: traffic-
related air pollution and roadway noise. A 
review of > 60 studies on transportation noise 
and cardiovascular risk concluded there was 
sufficient evidence for an association between 
traffic noise and ischemic heart disease, lim-
ited to sufficient evidence for an association 
with hypertension, and no consistent evidence 
for the individual SBP and DBP measures 
(Babisch 2006). None of the studies were 
reported to have specifically addressed PP. The 
author noted that several issues may dilute 
effect, including migration of sensitive people 
out of high-noise areas, medication, and the 
exclusion of subjects with preexisting condi-
tions or hypertension when individual mea-
sures of blood pressure were studied. Despite 
inconsistent results, the increase in noise lev-
els with traffic volumes, and decreasing noise 
levels with distance (6 dB per doubling of 
distance from the road) have been well estab-
lished (Ouis 2001). Based on available data, 
the contribution of traffic noise to elevated PP 
cannot be excluded in this study.
Negative associations. Contrary to a prior 
study, we found that those without, rather 
than with, diabetes had higher significant 
associations with traffic for some traffic indi-
ces, including traffic density, and to a lesser 
extent with proximity within 200 m of a road 
(Dubowsky et al. 2006). Although not statis-
tically significant, individuals with diabetes 
showed a consistent negative association with 
CRP and almost all traffic indices in what 
could be a result of the anti-inflammatory 
effects of noninsulin medications (Chu et al. 
2002; Dandona et al. 2004).
A consistently negative association, 
although not significant, was also observed 
between CRP and all traffic indices for indi-
viduals with BMI < 30. Interleukin 6 (IL-6), 
the cytokine primarily responsible for stimula-
tion of CRP, is produced in adipose tissue, and 
both IL-6 and CRP are found at higher circu-
lating levels in individuals with higher body 
fat (Dandona et al. 2004; Yudkin et al. 1999, 
2000). The negative associations seen in non-
obese individuals could also be the result of 
an anti-inflammatory effect of diabetes medi-
cations in a population with generally lower 
adipose-generated levels of IL-6 and lower 
CRP. Approximately 30% of those with BMI 
< 30 have diabetes, although the level of dia-
betes among those with BMI ≥ 30 is > 50%. 
The use of statins, also shown to have anti-in-
flammatory effects (Albert et al. 2001; Ridker 
et al. 1999) is approximately 30% in those 
with BMI < 30 and 42% in those with BMI 
≥ 30. The role of anti-inflammatory medica-
tions in mediating the inflammatory response 
to traffic will be examined in a future paper 
(Rioux CL, Tucker KL, Brugge D, Gute DM, 
Mwamburi M, unpublished data).
Strength and limitations. Our findings 
may be limited in their generalizability. The 
study population was Puerto Rican, predomi-
nantly low income, and had high prevalence 
of preexisting cardiovascular disease. It is prob-
ably reasonable, however, that our findings be 
compared with other older populations with 
high degrees of morbidity. Although this anal-
ysis provides new evidence regarding traffic-
related health impacts at the local scale, the 
cross-sectional nature of the study and the 
use of surrogate rather than direct measures of 
traffic-related noise and air pollution are limi-
tations. Surrogates of traffic exposures such as 
road proximity and traffic density, although 
capturing some of the variation in local traffic 
environments, do not capture the actual tem-
poral and spatial variations or migration and 
degradation profiles of the actual pollutant 
mix that originates from roadways that may 
be the underlying causal agents for adverse 
health effects. Time and activity relationships 
among the exposed population, including the 
relative time spent inside and outside of the 
home and differences between ambient air 
concentrations and those in the indoor envi-
ronment that originate from outdoor sources, 
are important considerations that we did not 
account for. The degree to which traffic-related 
health effects result from acute versus chronic 
exposures remains an ongoing research area. 
A combination of daily peak or shorter-term 
exposures and longer-term exposures is likely 
to contribute to the underlying mechanisms 
for cardiovascular illnesses. The biomarkers 
we examined, PP and CRP, have been associ-
ated with both short-term and longer-term 
exposures. The median length of residence in 
our study population was 5 years, and no con-
sistent difference in outcomes was observed 
when models were stratified by length of resi-
dence. For outcomes like lung cancer, lon-
ger exposure durations may be more relevant; 
however, we remain convinced that residential 
exposures in the time frames observed for this 
study population are meaningful for the bio-
markers examined.
The TAZ approach, despite limitations, 
was a robust predictor of CRP, which was 
generally confirmed by other traffic indices 
within a subpopulation group, for example, 
individuals with BMI ≥ 30. Notable among 
the limitations of the TAZ approach was the 
potential for exposure misclassification for 
individuals residing near a TAZ boundary but 
who would be expected to be influenced to 
some degree by the traffic impacts of an adja-
cent TAZ. The raster-based density approach 
was developed to address these intra-TAZ 
influences. Another limitation of the TAZ 
approach is that the traffic density estimates 
encompass automobiles and trucks but not 
buses, which may be a significant contributor 
to the overall pollution load in certain areas 
(Levy et al. 2001).
People residing within the 200-m buffers 
may have very different exposure levels as a 
result of their exact distance from the road, Rioux et al.
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the location of apartments within a building, 
the condition of windows, infiltration rates, 
and ventilation systems within the building. 
Ambient levels of traffic-related pollution and 
noise are higher at locations within meters 
of a roadway than at the farthest edge of the 
200-m buffer. Topographic features such as 
trees and other buildings may also reduce traf-
fic impacts within the 200-m buffer. A review 
of wind direction distribution from Boston 
Logan Airport in Boston indicates a chang-
ing pattern of wind directions in the Boson 
area. Five months of the year, the predomi-
nant wind direction is from the west (fall and 
winter), 6 months from the east (spring and 
summer), and 1 month (July) from the south 
(Windfinder 2009). Orientation of homes 
with respect to roadways was not considered 
and could influence the magnitude of expo-
sure, with increasing exposures downwind 
versus crosswind. People spend different 
amounts of time at home, reflecting variation 
in actual residential traffic exposure. A low 
employment rate (20%) among this older 
population suggests time spent at home was 
relatively high, although variation could arise 
from travel outside the home for purposes 
other than employment.
Strengths of this study include the extent of 
covariate information on health-related behav-
iors (smoking, alcohol consumption, physical 
activity levels), comorbidities (hypertension, 
prior heart attack, and heart disease), physi-
ologic markers of health status (HDL, LDL, 
blood pressure, and other markers of inflam-
mation including serum albumin, platelet, 
and WBC counts), and socioeconomic fac-
tors (income/poverty levels, education, health 
insurance, and other social support factors) that 
could be used to develop and adjust the models 
and develop a clearer picture of the associations 
between traffic and the outcome of concern. 
Traffic data, including traffic count statistics on 
vehicles per day and the TAZ-level traffic den-
sity information, allowed for a detailed charac-
terization of the variability of traffic exposure 
conditions across the study area.
Conclusions
In this study we found that adverse health 
effects were associated with residence near 
roadways with traffic volumes between 20,000 
and 40,000 vehicles/day, suggesting risks 
from residential exposure at lesser roadway 
volumes than previously reported. Individuals 
with BMI ≥ 30 had higher levels of CRP and 
exhibited stronger statistical associations with 
traffic exposure indices and both CRP and 
PP. These findings provide suggestive evidence 
that a) inflammation may mediate the effects 
of traffic exposure; and b) individuals with 
conditions associated with elevated inflam-
matory profiles may be particularly suscep-
tible to the adverse effects of traffic exposure. 
Assessment of residential traffic exposure using 
several different traffic indicators is a robust 
method for investigating the role of distance to 
roadway, traffic volume, dose response, cumu-
lative impacts, and high-volume, single-source 
versus multidirectional overall traffic density 
on adverse health outcomes from traffic.
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